1 year return (CAGR)
-30.50%
Taysha Gene Therapies Inc Exchange (NASDAQ, USD)
TSHA
4.13
-0.07 (-1.96%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
9.41%
5 year return (CAGR)
-28.09%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.14B
Price/Sales
208.51
Ent value
771.44M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.51 |
| Daily high | 3.71 |
| Daily low | 3.46 |
| Daily Volume | 4.34M |
| All-time high | 31.75 |
| 1y analyst estimate | 13.00 |
| Beta | 1.17 |
| EPS (TTM) | -0.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TSHA | S&P500 | |
| Current price drop from All-time high | -86.99% | -3.00% |
| Highest price drop | -98.14% | -56.47% |
| Date of highest drop | 28 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -77.13% | -10.65% |
| Avg time to new high | 217 days | 12 days |
| Max time to new high | 1441 days | 1805 days |
News
